Literature DB >> 31080143

The Influence of Race, Ethnicity and Genetic Variants on Postoperative Pain Intensity: An Integrative Literature Review.

Mallory Perry1, Kyle Baumbauer2, Erin E Young3, Susan G Dorsey4, Jacquelyn Y Taylor5, Angela R Starkweather6.   

Abstract

OBJECTIVES: Chronic postsurgical pain is pain that develops and persists for at least 3 months after a surgical procedure. The purpose of this review was to discover what evidence exists regarding the influence of race and ethnicity on postoperative pain intensity and what evidence exists regarding the influence of genetic polymorphisms on postoperative pain intensity.
DESIGN: Integrative literature review. DATA SOURCES: CINAHL, PsychInfo, SCOPUS, and PubMed/Medline databases were searched for entries within the last 10 years. Sources included primary research investigating the relationship among race, ethnicity, and genetics in postoperative pain outcomes. REVIEW/ANALYSIS
METHODS: Studies adhered to a strict inclusion and exclusion criteria. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were utilized to evaluate and assess manuscripts for inclusion.
RESULTS: Twelve manuscripts were included for final review. There are significantly higher preoperative and postoperative pain intensity scores reported between African American and Hispanic individuals compared with non-Hispanic whites. Although some studies identified that non-Hispanic whites consumed more opioids and reported increased pain, there were no significant differences in opioid requirements in Hispanic and non-Hispanic individuals. COMT and OPRM1 were the most identified genetic polymorphisms associated with postoperative pain intensity.
CONCLUSIONS: The literature varies with respect to race, ethnicity, and postoperative pain perception. Perioperative pain intensity has been suggested as a significant predictor of chronic postsurgical pain. COMT and OPRM1 may be associated with higher pain perception after surgical procedures.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31080143     DOI: 10.1016/j.pmn.2018.11.002

Source DB:  PubMed          Journal:  Pain Manag Nurs        ISSN: 1524-9042            Impact factor:   1.929


  6 in total

1.  Neuronal-enriched extracellular vesicles in individuals with IBS: A pilot study of COMT and BDNF.

Authors:  Kristen R Weaver; Maja Mustapic; Dimitrios Kapogiannis; Wendy A Henderson
Journal:  Neurogastroenterol Motil       Date:  2021-09-09       Impact factor: 3.960

2.  Initial experience with novel CGRP-receptor inhibitor therapy in Migraine in the United Arab Emirates: a retrospective observational study.

Authors:  Bui Bao Khanh Dinh; Waseem Hamed Aziz; Alessandro Terruzzi; Derk Wolfgang Krieger
Journal:  BMC Neurol       Date:  2021-12-14       Impact factor: 2.474

Review 3.  Does ethnicity affect pain management for people with advanced disease? A mixed methods cross-national systematic review of 'very high' Human Development Index English-speaking countries.

Authors:  Gemma Clarke; Emma Chapman; Jodie Crooks; Jonathan Koffman; Shenaz Ahmed; Michael I Bennett
Journal:  BMC Palliat Care       Date:  2022-04-06       Impact factor: 3.234

4.  Effectiveness of Acupuncture for Pain Control After Cesarean Delivery: A Randomized Clinical Trial.

Authors:  Taras I Usichenko; Berthold Johannes Henkel; Catharina Klausenitz; Thomas Hesse; Guillermo Pierdant; Mike Cummings; Klaus Hahnenkamp
Journal:  JAMA Netw Open       Date:  2022-02-01

5.  Race, ethnicity, and the use of regional anesthesia in cancer patients undergoing open abdominal surgery: A single-center retrospective cohort study.

Authors:  Pascal Owusu-Agyemang; Lei Feng; Vivian H Porche; Uduak U Williams; Juan P Cata
Journal:  Front Med (Lausanne)       Date:  2022-08-18

6.  The Effect of Rhythmic Breathing on the Severity of Sternotomy Pain after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Clinical Trial.

Authors:  Hassan Babamohamadi; Masoumeh Karkeabadi; Abbasali Ebrahimian
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.